Born in June 1988, Nanyang, Henan Province, M.D., Peking Union Medical College, Master's Degree Tutor. He is the Deputy Secretary General of Henan Health Industry Development Association, member of Henan Infectious Disease and Biosafety Professional Committee, member of Henan Infection and Molecular Immunology Professional Committee, member of Medical Ethics Professional Committee of Henan Anti-cancer Association, member of the Second Council of Henan Science and Health Care Society.
After graduation of PhD in 2019, he joined the School of Basic Medical Sciences, Department of Public Health and Epidemiology, Henan University, and the Engineering and Technology Research Centre for Tumour Molecular Diagnosis and Precision Therapy of Henan Province.February 2022-December 2022: Seconded to the National Natural Science Foundation of China, Department of Microbiology, Division of Life Sciences.March 2023-May 2023 March 2023-May 2023: Part-time in the Office of the Party Committee of the College.
In 2022, preside over 1 youth project of National Natural Science Foundation of China (300,000, under research).
In 2021, she will preside over 1 key R&D and promotion special project (scientific and technological research) in Henan Province (100,000, completed).
In 2024, preside over 1 key R&D and promotion project of Henan Province (scientific and technological research) (already announced).
In 2020, preside over 1 project of Henan Province Youth Tuojiao Talent Project (50,000, concluded).
In 2020, he will preside over one postdoctoral fund project in Henan Province (50,000, completed).
In 2023, as the main participant, he will be approved for one general project of National Social Science Foundation of China (200,000, under research).
In 2024, as the main participant, he was approved for 1 project of Medical Science and Technology Research Project of Henan Province (30,000, under research).
Completed 2 National Natural Science Foundation of China projects as the main participant.
1.Xiaoyang Gao; Yeting Xia; Xiaofang Liu; Yin lan Xu; Pengyang Lu; Zhipeng Dong; Jing Liu ; Gaofeng Liang ; A perspective on SARS-CoV-2 virus-like particles vaccines, International Imunopharmacology, 2023, 115: 109650.
2. Jing Liu ; Tiecheng Wang; Ying Xie ; Yuanguo Li ; Jian He ; Xinghai Zhang; Weiyang Sun; Na Feng; Chuan Qin; Yuwei Gao; Xianzhu Xia ; Neutralization activity of influenza A virus humanized antibodies against new subtypes of influenza viruses, Biosafety and Health, 2019, 1(3): 159-
161.
3. Jing Liu ; Zhiguang Ren; Hongmei Wang; Yongkun Zhao; Peter R. Wilker; Zhijun Yu; Weiyang Sun; Tiecheng Wang; Na Feng; Yuanguo Li ; Hualei Wang; Xianliang Ji ; Nan Li ; Songtao Yang; Hongbin He ; Chuan Qin; Yuwei Gao; Xianzhu Xia ; Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses, International Imunopharmacology, 2018, 63: 119-128.
4. Zhiguang Ren; Yongkun Zhao; Jing Liu ; Xianliang Ji ; Lingnan Meng; Tiecheng Wang; Weiyang Sun; Kun Zhang; Xiaoyu Sang; Zhijun Yu; Yuanguo Li ; Na Feng; Hualei Wang; Songtao Yang; Zhengyan Yang; Zhizeng Wang; Yuwei Gao; Xianzhu Xia ; Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and
oral immunization of mice, Vaccine, 2018, 36(40): 5990-5998.
5. Zhiguang Ren; Yongkun Zhao; Jing Liu ; Xianliang Ji ; Lingnan Meng; Tiecheng Wang; Weiyang Sun; Kun Zhang; Xiaoyu Sang; Zhijun Yu; Yuanguo Li ; Na Feng; Hualei Wang; Songtao Yang; Zhengyan Yang; Yuanfang Ma; Yuwei Gao; Xianzhu Xia ; Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge, International Imunopharmacology, 2018, 58: 109-116.
6. LIU Jing, REN Zhiguang, WANG Tiecheng, et al. Preparation of a generic H5N1 subtype avian influenza virus-like particle vaccine[J]. Chinese Journal of Pathogen Biology, 2019, 014(007):755-760.
Gao Xiaoyang, Liu Jing, Liang Gaofeng. Prospects for a broad-spectrum influenza vaccine based on cytotoxic T lymphocytes. Chinese Journal of Pathogen Biology, 2023,18(02):238-242247.
